SOLOIST WHF：SOLOIST
SOLOIST
INPEFAisindicatedtoreducetheriskofcardiovasculardeath,hospitalizationforheartfailure,andurgentheartfailurevisitinadults.。其他文章還包含有：「SotagliflozininPatientswithDiabetesandRecent...」、「NCT03521934」、「EffectofSotagliflozinonCardiovascularEventsinPatients...」、「EffectofSotagliflozinonEarlyMortalityandHeartFailure...」
查看更多 離開網站
Sotagliflozin in Patients with Diabetes and Recent ...
https://www.nejm.org
The SOLOIST-WHF trial was a phase 3, double-blind, randomized, placebo-controlled trial. Sanofi was the original sponsor; sponsorship was ...
NCT03521934
https://clinicaltrials.gov
沒有這個頁面的資訊。
Effect of Sotagliflozin on Cardiovascular Events in Patients ...
https://www.acc.org
The SOLOIST-WHF trial showed that sotagliflozin has salutary effects on CV outcomes among patients with T2DM and HF.
Effect of Sotagliflozin on Early Mortality and Heart Failure ...
https://www.jacc.org
In the SOLOIST-WHF trial primary analysis, the administration of sotagliflozin resulted in a significantly lower number of cardiovascular deaths ...